Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2025-12-28 @ 11:33 AM
Study NCT ID:
NCT02000050
Status:
COMPLETED
Last Update Posted:
2025-01-30
First Post:
2013-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)
Sponsor:
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-11
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-15
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-26
First Submit QC Date:
None
Study First Post Date:
2013-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-29
Last Update Post Date:
2025-01-30
Last Update Post Date Type:
ACTUAL